ArticleFrontiers in pharmacology2022

Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma.

Ganggang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.